Per discussions with various injectors, there is a learning curve of about 4 months when switching from a 3 month toxin to Daxi! Allergan’s position to injectors is that using Daxi will lower the annual patient visits and hence net profit to the practice which is 100% a smoke screen! Allegan also offers injectors/practices big discounts on their other aesthetic products for buying Botox. This practice should be illegal, as this is a medical prescription product! Daxi actually increases profit per hour of injectors and saves patients money! Allergan just recently held a high level management meeting to keep morale up and brainstorm ways to stop Daxi from taking Botox market share! Botox is 20 plus years old and losing cosmetic market share every quarter! Botox is the profit center for Allergan, so every 1% market share lost is very painful!
On the therapeutic side, there will be a large wave of MDs who will use Daxi for off label indications because it lasts 16 to 24 weeks. These injections are just starting!!! I have friends who get therapeutic injections and their MDs have told them that they are being switched to Daxi.
The frontalis is an off label indication and can only be discussed by MSLs and injectors doing private training! The key to Daxi is placing the toxin in the middle of the muscle since Daxi does not migrate every where like Botox! Botox must be place slightly above the gabellar muscle so it does not migrate down to other muscles which cause droopy eye. As more and more patients, become aware of Daxi, injectors will be forced to offer Daxi or lose patients to competition.
News 
Market Data 
Discover 
